Cardiac Science Corp. (NSDQ:CSCX) and electronic medical records provider Medent inked a connectivity deal that will link Cardiac Science’s monitoring devices and defibrillators to Medent’s EMR system.
Bothell, Wash.-based CSCX said the deal opens up Auburn, N.Y.-based Medent‘s 12,000-physician customer base to offices that use its Quinton and Burdick ECG, cardiac stress test and Holter systems. Offices using both companies’ equipment and Cardiac Science’s HeartCentrix connectivity solution will be able to send patients’ data from diagnostic and monitoring devices into their EMRs.
Medent Vice President George Cuthbert noted that the deal also goes toward helping the companies’ clients meet so-called “meaningful use” requirements contained in the American Recovery and Reinvestment Act. That law makes about $20 billion available to promote the use of EMR technology, to the tune of up to $40,000 per physician over the course of several years to practices that can demonstrate meaningful use of the technology.